Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Kristina Hoelig, MD, Helmuth Schmidt, MD, Gero Hütter, MD, Michael Kramer, Raphael Teipel, MD, Kristin Zimmer, MD, Matthias Blechschmidt, MD, Tigran Torosian, MD, Rainer Ordemann, MD, Frank Kroschinsky, MD, Alexander H. Schmidt, MD PhD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc

Blood (2016) 128 (22): 3369.

https://doi.org/10.1182/blood.V128.22.3369.3369

Published: 2016

Journal Articles

Prediction of Hematopoietic Stem Cell Yield after Mobilization with GCSF in Healthy Unrelated Donors

Raphael Teipel, MD, Johannes Schetelig, MD M. Sc,, Michael Kramer, PhD, Helmuth Schmidt, MD, Alexander H. Schmidt, MD PhD, Christian Thiede, MD, Kristina Hoelig, MD, Gerhard Ehninger, MD

Blood (2014) 124 (21): 1128.

https://doi.org/10.1182/blood.V124.21.1128.1128

Published: 2014

Journal Articles

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Frank P. Kroschinsky, MD, Eberhard Schleyer, MD, Kristina Hoelig, MD, Uta Oelschlaegel, PhD, Rainer Ordemann, MD, Kirsten Poppe-Thiede, MD, Markus A. Schaich, MD, Claudia Rutt, MD, Gerhard Ehninger, MD

Blood (2005) 106 (11): 5321.

https://doi.org/10.1182/blood.V106.11.5321.5321

Published: 2005

Journal Articles

Single-Dose Pegfilgrastim after Chemotherapy Is Highly Effective in Enhancing the Mobilization of Autologous CD34+ Peripheral Blood Stem Cells in Patients with Lymphoid Malignancies and Solid Tumors.

Frank Kroschinsky, MD, Kristina Hoelig, MD, Uwe Platzbecker, MD, Eberhard Schleyer, MD, Rainer Ordemann, MD, Astrid Haack, Markus Schaich, MD, Martin Bornhaeuser, MD, Gerhard Ehninger, MD

Blood (2004) 104 (11): 2922.

https://doi.org/10.1182/blood.V104.11.2922.2922

Published: 2004

Journal Articles

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Frank Kroschinsky, MD, Kristina Hoelig, MD, Rainer Ordemann, MD, Astrid Haack, Kirsten Poppe-Thiede, MD, Matthias Blechschmidt, MD, Gabi Rall, Martin Bornhaeuser, MD, Eberhard Schleyer, MD, Claudia Rutt, Gerhard Ehninger, MD

Blood (2004) 104 (11): 5003.

https://doi.org/10.1182/blood.V104.11.5003.5003

Published: 2004

NARROW

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Prediction of Hematopoietic Stem Cell Yield after Mobilization with GCSF in Healthy Unrelated Donors

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Single-Dose Pegfilgrastim after Chemotherapy Is Highly Effective in Enhancing the Mobilization of Autologous CD34+ Peripheral Blood Stem Cells in Patients with Lymphoid Malignancies and Solid Tumors.

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Plerixafor As a Salvage Regimen to Mobilize Allogeneic Stem Cells in Healthy Volunteers (NCT01954914)

Prediction of Hematopoietic Stem Cell Yield after Mobilization with GCSF in Healthy Unrelated Donors

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Single-Dose Pegfilgrastim after Chemotherapy Is Highly Effective in Enhancing the Mobilization of Autologous CD34+ Peripheral Blood Stem Cells in Patients with Lymphoid Malignancies and Solid Tumors.

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only